IMMUNOGEL Trademark

Trademark Overview

On Friday, March 28, 2025, a trademark application was filed for IMMUNOGEL with the United States Patent and Trademark Office. The USPTO has given the IMMUNOGEL trademark a serial number of 99109845. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, October 16, 2025. This trademark is owned by H. Lee Moffitt Cancer Center and Research Institute, Inc.. The IMMUNOGEL trademark is filed in the Pharmaceutical Products category with the following description:

Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for humans for the treatment of cancer; Pharmaceutical products for humans for the treatment of cancer; Therapeutic pharmaceutical for humans for the treatment of cancer; Pharmaceutical preparations for humans for the treatment of cancer
immunogel

General Information

Serial Number99109845
Word MarkIMMUNOGEL
Filing DateFriday, March 28, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, October 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesImplantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for humans for the treatment of cancer; Pharmaceutical products for humans for the treatment of cancer; Therapeutic pharmaceutical for humans for the treatment of cancer; Pharmaceutical preparations for humans for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameH. Lee Moffitt Cancer Center and Research Institute, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTampa, FL 33612

Trademark Events

Event DateEvent Description
Friday, March 28, 2025NEW APPLICATION ENTERED
Friday, March 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 28, 2025APPLICATION FILING RECEIPT MAILED
Friday, May 30, 2025ASSIGNED TO EXAMINER
Friday, June 6, 2025NON-FINAL ACTION WRITTEN
Friday, June 6, 2025NON-FINAL ACTION E-MAILED
Friday, June 6, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 24, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 24, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 24, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 15, 2025REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Tuesday, July 15, 2025NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Tuesday, July 15, 2025NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Thursday, July 31, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 31, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 31, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 18, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 18, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 18, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 16, 2025NON-FINAL ACTION WRITTEN
Thursday, October 16, 2025NON-FINAL ACTION E-MAILED
Thursday, October 16, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

immunogel treatment humans pharmaceutical cancer preparations therapeutic products filled drug subcutaneous